Zimmer Biomet Holdings (ZIM) Financial Statements
Zimmer Biomet Holdings Financial Overview
Zimmer Biomet Holdings's market cap is currently $16.09B. The company's EPS TTM is $4.13; its P/E ratio is 22.89; and it has a dividend yield of 1.01%. Zimmer Biomet Holdings is scheduled to report earnings on November 4, 2026, and the estimated EPS forecast is $1.68. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.23B | $ 7.68B | $ 7.39B | $ 6.94B | $ 6.83B |
| Gross Profit | $ 5.07B | $ 5.49B | $ 5.31B | $ 4.92B | $ 4.87B |
| Operating Income | $ 1.36B | $ 1.29B | $ 1.28B | $ 696.30M | $ 860.30M |
| EBITDA | $ 2.22B | $ 2.25B | $ 2.22B | $ 1.49B | $ 1.65B |
| Net Income | $ 705.20M | $ 903.80M | $ 1.02B | $ 231.40M | $ 401.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 591.90M | $ 525.50M | $ 415.80M | $ 375.70M | $ 378.10M |
| Total Assets | $ 23.09B | $ 21.37B | $ 21.50B | $ 21.07B | $ 23.46B |
| Total Debt | $ 7.52B | $ 6.20B | $ 5.77B | $ 5.70B | $ 7.07B |
| Net Debt | $ 6.93B | $ 5.68B | $ 5.35B | $ 5.32B | $ 6.69B |
| Total Liabilities | $ 10.39B | $ 8.89B | $ 9.01B | $ 9.04B | $ 10.79B |
| Stockholders' Equity | $ 12.70B | $ 12.47B | $ 12.48B | $ 12.02B | $ 12.66B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.47B | $ 1.14B | $ 1.19B | $ 1.07B | $ 1.35B |
| Operating Cash Flow | $ 1.70B | $ 1.50B | $ 1.58B | $ 1.28B | $ 1.50B |
| Investing Cash Flow | $ -1.98B | $ -888.10M | $ -778.90M | $ -529.20M | $ -503.60M |
| Financing Cash Flow | $ 326.00M | $ -484.50M | $ -763.50M | $ -843.80M | $ -1.31B |
Currency in USD